Bone Infection clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Omadacycline Randomized Treatment Given for Bone and Joint Infection

    open to eligible people ages 18-85

    The study design is a randomized, open-label, clinical trial of omadacycline vs Standard of Care (SOC) antibiotics for bone and join infection (BJI) treatment. Study participants will have their BJI regimen chosen by their treating physicians,…

    Torrance, California

Our lead scientists for Bone Infection research studies include .

Last updated: